Aptorum Group Limited
APM
$4.75
-$0.35-6.86%
Headlines
4/30/2024
-
TipRanks Financial Blog
4/30/2024
-
Business Wire
4/13/2024
-
Ticker Report
3/27/2024
-
Ticker Report
3/19/2024
-
The Fly
3/19/2024
-
The Fly
3/12/2024
-
The Fly
3/12/2024
-
The Fly
3/8/2024
-
The Fly
3/8/2024
-
The Fly
3/7/2024
-
SeekingAlpha.com: All News
3/7/2024
-
Seeking Alpha - Healthcare
3/7/2024
-
The Fly
3/7/2024
-
The Fly
3/7/2024
-
Benzinga
3/6/2024
-
Benzinga
3/6/2024
-
SeekingAlpha.com: All News
3/6/2024
-
Seeking Alpha - Healthcare
3/6/2024
-
Business Wire
1/26/2024
-
Ticker Report
1/13/2024
-
Ticker Report
1/2/2024
-
Zolmax
12/26/2023
-
SeekingAlpha.com: All News
12/22/2023
-
Business Wire
Filings
Tuesday, April 30, 2024
Sunday, December 31, 2023
Week of Dec 16 and 20 (est)
Price History
Corporate Info
44 20 8092 9299
17 Hanover Square
London, W1S 1BN
London, W1S 1BN
Business Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The...
more